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To determine the efficacy of repeat percutaneous translu- 
minal coronary angioplasty, 74 patients were studied who 
underwent a third angioplasty for a second restenosis of one 
coronary artery segment. The procedure was successful in 
93% of patients. Procedural complications included emer- 
gency bypass surgery (three patients) and in-hospital death 
(two patients). At late follow-up (mean 18 months, range 7 
to 49), 30 patients (43%) had a third restenosis treated with 
either a fourth angioplasty (16 patients), coronary bypass 
surgery (11 patients) or medical management (1 patient). 
Thirty-nine patients (57%) had no restenosis on the basis of 
follow-up angiography or absence of symptoms previously 
attributed to restenosis. Factors associated with a third 
restenosis included a shorter time interval (<3 months) 
between previous angioplasty procedures and dilation of 
the left anterior descending coronary artery. 
Among the 16 patients undergoing a fourth angioplasty 
for a third restenosis, the procedural success rate was 94%. 
Despite high initial success rates, the long-term success of 
percutaneous transluminal coronary angioplasty has been ham- 
pered by the problem of restenosis. Restenosis rates of 12 to 
38% have been reported (l-13). Because its efficacy has been 
well documented, performance of a second angioplasty after 
the first restenosis has become a routine clinical practice. 
Unfortunately, restenosis rates after a second angioplasty 
procedure are also high, ranging from 26 to 34% in two reported 
series (14,15). As more patients undergo coronary angioplasty, 
the problem of recurrent restenosis has become more common. 
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One patient required emergency bypass surgery. At late 
follow-up (mean 16 months, range 7 to 38), eight patients 
(53%) had a fourth restenosis treated with either a fifth 
angioplasty (one patient), bypass surgery (five patients) or 
medical management (two patients). 
Considering all 74 patients undergoing a third angio- 
plasty for a second restenosis, 27% had bypass surgery, 5% 
died, 4% were managed medically and 64% were free of 
angina at late follow-up after either a third, fourth or fifth 
angioplasty. 
Restenosis rates after a third or fourth angioplasty 
procedure for recurrent restenosis are higher than those for 
the initial procedures. The rate of restenosis after the third 
and fourth dilation is approximately 50%. However, in this 
study, multiple repeat angioplasty procedures provided 
effective long-term therapy for 64% of patients presenting 
with a second restenosis. 
(J Am Co11 Cardiol1989;13:291-6) 
The patient, angioplasty operator and referring physician face a 
difficult decision. Is a third procedure likely to provide pro- 
longed success, or is coronary bypass surgery more desirable? 
To help guide this decision, this study describes the procedural 
outcome and long-term follow-up of 74 patients undergoing a 
third angioplasty for a second restenosis. 
Methods 
Study patients. Our study group consisted of patients 
who underwent three or more angioplasty procedures be- 
cause of recurrent restenosis of one coronary artery seg- 
ment. Restenosis was defined angiographically as >50% 
diameter narrowing of a coronary segment that was previ- 
ously dilated to ~40% residual diameter stenosis. A mini- 
mum of 2 weeks between procedures was specified to 
exclude patients who had repeat dilation because of an acute 
or semi-acute complication of the preceding procedure. 
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Between February 1980 and April 1986,5,200 angioplasty 
procedures were performed and entered into our data base. 
During this time period, 170 patients underwent three or 
more procedures. Eighty-three patients were excluded be- 
cause they had multiple angioplasty procedures on several 
lesions, such that no single coronary artery segment was 
dilated on three or more occasions. Thirteen patients were 
excluded because they had their second or third angioplasty 
within 2 weeks of the preceding procedure (eight patients 
within 3 days and five patients within 6 days). The remaining 
74 patients formed our study group. All had three or more 
angioplasty procedures for two or more restenoses of one 
coronary artery segment. 
Angioplasty procedure. Angioplasty was performed as 
previously described (16). Routine preprocedure medica- 
tions included aspirin, dipyridamole and a calcium channel 
blocker. Routine procedural medications included heparin 
(10,000 U intravenously), sublingual isosorbide dinitrate, 
diazepam, lidocaine, atropine and a low molecular weight 
dextran infusion. Dilation was considered successful if the 
residual luminal narrowing was ~40% of the vessel diameter 
in all angiographic views in the absence of major complica- 
tions. Transstenotic pressure gradients were not routinely 
measured. Major complications were defined as 1) death 
during the procedure or related hospitalization; 2) emer- 
gency coronary bypass surgery, defined as surgery per- 
formed during the angioplasty-related hospitalization be- 
cause of ongoing ischemia; and 3) transmural myocardial 
infarction. After the procedure an intravenous heparin infu- 
sion was maintained for 12 to 24 h. If the coronary artery was 
extensively traumatized and the zone of dilation appeared 
disrupted, the heparin infusion was continued for 36 to 48 h. 
Patients were discharged on treatment with long-acting 
nitrate, aspirin, dipyridamole and a calcium channel blocker 
for a minimum of 6 months. 
Long-term follow-up. Late follow-up was 100% com- 
plete. All patients were contacted by telephone and queried 
with respect to 1) current angina1 status; 2) angina1 status 
before and after all prior angioplasty procedures; 3) interim 
occurrence of myocardial infarction, coronary bypass sur- 
gery or subsequent angioplasty. The result of a follow-up 
treadmill exercise test was obtained whenever possible. The 
follow-up exercise test was judged positive when the patient 
experienced angina or developed ST segment depression 
2 1.5 mm in any electrocardiographic (ECG) lead. 
Statistics. Comparisons were made with use of the Stu- 
dents t test for continuous variables and the chi-square or 
Fisher’s exact test for categorical variables. 
Results 
Baseline characteristics of the 74 patients (Table 1). There 
were 54 men and 20 women whose mean age was 60 years. 
Sixty-three patients (85%) had more than one lesion dilated 
Table 1. Baseline Characteristics of 74 patients Undergoing a 
Third Angioplasty for a Second Restenosis 
Patients 
Men 
Age (mean 60 yr, range 35 to 82) 
Ejection fraction <40% 
Previous CABG 
Cholesterol (mean 216 mgidl) 
Cholesterol >240 mgidl 
Diabetes mellitus 
Smoking after third angioplasty 
Cholesterol >240 mgidl. diabetes or smoking 
after third angioplasty 
Dilation site 
LAD 
LCX 
RCA 
SVG 
Multiple vessels 
LAD t LCx 
LCx + RCA 
LCx (2 sites) 
No. 7% 
54 73 
7 IO 
I1 I5 
I7 23 
14 I9 
IO I4 
32 43 
37 50 
IO I4 
IS 20 
5 1 
7 9 
5 
I 
I 
CABG = coronary artery bypass surgery; LAD = left anterior descending 
coronary artery: LCx = left circumflex artery; RCA = right coronary artery; 
SVG = saphenous vein graft. 
during their initial angioplasty procedure. Seven patients 
(10%) had a global left ventricular ejection fraction of ~40% 
and 11 patients (15%) had previous coronary bypass surgery. 
The mean serum cholesterol level was 216 mgldl and 17 
patients (23%) had a value >240 mgidl. Diabetes mellitus 
(requiring insulin or oral hypoglycemic agent) was present in 
14 patients (19%) and 10 patients continued to smoke ciga- 
rettes after their third angioplasty procedure. At least one of 
these three clinical factors (cholesterol >240 mgldl, diabetes 
mellitus or continued smoking) was present in 32 patients 
(43%). 
Of the 74 patients presenting for the third procedure, 37 
(50%) had dilation of the left anterior descending coronary 
artery, 10 (14%) of the left circumflex artery, 15 (20%) of the 
right coronary artery and 5 (7%) of a saphenous vein graft; 7 
(9%) had dilation of recurrent restenoses in more than one 
vessel. The mean time interval between the first and second, 
the second and third and the third and fourth angioplasty was 
6.4, 5.7 and 8.3 months, respectively. 
Procedural outcome of the third angioplasty. Of the 74 
patients undergoing a third procedure, 93% had a successful 
dilation. Five patients sustained procedural complications. 
Three of these five required emergency coronary bypass 
surgery and survived; the other two did not undergo emer- 
gency surgery and died (see Discussion). The remaining 69 
patients were followed up for a mean of 18 months (range 7 
to 49). 
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Table 2. Late Outcome of 69 Patients With a Successful Third 
Angioplasty: Third Restenosis Absent 
Table 4. Factors Associated With a Third Restenosis 
Patients 
Asymtomatic (7 to 49 months) 
Angiography: no restenosis 
Angiography not performed 
Return of angina 
34 
4 
30 
Angiography: new lesions 5 
Total patients with no third restenosis 39 (57“%) 
Follow-up of patients without a third restenosis. Of the 69 
patients with a successful third angioplasty procedure, a 
total of 39 (57%) were classified as having no third restenosis 
by the clinical or angiographic criteria indicated in Table 2. 
Thirty-four patients (48%) were asymptomatic, and four of 
these had follow-up angiographic confirmation of no reste- 
nosis. The remaining 30 asymptomatic patients who did not 
undergo follow-up angiography were asked to compare their 
symptoms before each of the three preceding angioplasty 
procedures with their symptomatic status at follow-up. All 
could identify specific angina1 symptoms that were initially 
relieved but later returned after the first and second dilation. 
All were again relieved of symptoms by the third dilation and 
all remained asymptomatic at follow-up. Of these 30 asymp- 
tomatic patients, 25 had a follow-up treadmill test. This test 
was negative in 24 (96%) of the 25 patients; in 1 patient the 
test revealed 1.0 mm ST segment depression at peak exer- 
cise, but the patient had no associated angina. 
Age tyrt (meant 
Men 
Ejection fraction <40% 
Cholesterol (mean) (mgidl) 
Cholesterol >!40 mgidl 
Diabetes mellitus 
Smoking after third 
angiopla>ty 
Cholesterol >?40 mgidl, 
diabetes or smoking 
Percent stenosis (mean) 
before third angioplasty 
Stenosis 295% before 
third angioplasty 
Restenosis 
(n = 30) 
61 
24 (80%) 
4 (13%) 
?I0 
7 (23%) 
h (20%) 
5 (17%) 
I4 147%) 
86% 
9 (30%) 
No 
Restenosis 
(n = 39) 
62 
14 (617~) 
2 (547) 
23 
IO t?6%,) 
7 (18%) 
5 (13%,) 
I7 (44%) 
79”lr 
6 (16%) 
P 
Value 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
Five additional patients who described recurrence of their 
typical angina1 symptoms were classified as having no third 
restenosis because angiography documented new coronary 
lesions without restenosis of the previously dilated coronary 
segment. 
Follow-up of patients with a third restenosis. Of the 69 
patients with a successful third angioplasty, 30 (43%) were 
classified as having a third restenosis (Table 3). Twenty- 
seven of these patients had typical angina1 symptoms and 
angiographic documentation of restenosis. One additional 
patient who had a return of typical angina1 symptoms refused 
angiography. Two other patients died late of cardiac causes 
(see later) and were classified as having a third restenosis. 
Sixteen patients with a third restenosis were treated with a 
repeat (fourth) angioplasty, I1 underwent bypass surgery 
and I patient was treated medically. 
Clinical and anatomic factors associated with a third 
restenosis. Neither age, gender, left ventricular ejection 
fraction <40%, serum cholesterol level, presence of diabetes 
mellitus, continued smoking or percent diameter stenosis 
were associated with a third restenosis (Table 4). The mean 
time intervals from the first to the second and from the 
second to the third angioplasty procedure were both shorter 
in patients who subsequently developed a third restenosis 
(5.2 and 4.9 months, respectively) than in patients with no 
third restenosis (7.4 and 6.4 months, respectively) (p = NS). 
When both time intervals were 53 months, 8 (72%) of 11 
patients had a third restenosis compared with 22 (38%) of 58 
patients in whom either interval was >3 months (p < 0.05). 
Restenosis rates after the third angioplasty corresponding 
to the specific vessel dilated are depicted in Figure 1. 
Restenosis rates were highest for the left anterior descending 
artery (56%; p < 0.05) and the saphenous vein graft (50%). 
Figure 1. Restenosis values in 64 patients after the third coronary 
angioplasty according to the specific vessel dilated. CIRC = left 
circumflex artery: LAD = left anterior descending coronary artery; 
RCA = right coronary artery; SVG = saphenous vein graft. *p < 
Table 3. Late Outcome of 69 Patients With a Successful Third 
Angioplasty: Third Restenosis Present 
Patients 
Return of angina: 
Restenosis at angiography 
Return of angina: 
Angiography refused 
Late cardiac death 
Total patients with a third restenosis 
27 
I 
? 
30 (43%:) 
~ 
N = 15 
I 
I 
I 
I N=1 
SVG RCA CIRC 
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Table 5. Late Outcome of 15 Patients With a Successful 
Fourth Angioplasty 
Patients . 
No. % 
Fourth restenosis absent 
(all asymptomatic at 7 to 38 mo) 
Fourth restenosis present 
Symptomatic: angiographic confirmation 
Symptomatic: refused angiography 
7 47 
8 53 
6 
2 
The restenosis rate for the 15 patients undergoing right 
coronary dilation was only 13% and none of the 8 patients 
undergoing left circumflex dilation had a third restenosis. 
Outcome of the fourth angioplasty. Of the 16 patients 
undergoing a fou 
r 
,.procedure for a third restenosis, 94% 
had a successful dt ation. One emergency coronary bypass 
operation was performed, and there were no procedural 
deaths or myocardial infarctions. The remaining 15 patients 
were followed up for a mean of 16 months (range 7 to 38). 
There were no late deaths or myocardial infarctions. Seven 
patients (47%) remained free of angina at follow-up and, 
therefore, were classified as having no fourth restenosis 
(Table 5). Eight patients (53%) had a return of their angina1 
symptoms and, therefore, were classified as having a fourth 
restenosis. Restenosis was documented at angiography in six 
of these eight patients. Two patients refused angiography. 
Of the eight patients with a fourth restenosis, five had 
coronary bypass surgery, and two were treated medically; 
one patient underwent a repeat (fifth) coronary angioplasty 
and is asymptomatic after 15 months of follow-up (angiog- 
raphy performed 8 months after the fifth angioplasty dem- 
onstrated no further restenosis). 
Of all 74 patients undergoing a third angioplasty for a 
second restenosis, 27% eventually underwent coronary by- 
pass surgery, 5% died, 4% were managed medically and 64% 
were free of angina at late follow-up after either a third, 
fourth or fifth procedure (Fig. 2). 
Discussion 
This study is the first to examine the long-term efficacy of 
a third coronary angioplasty when two previous procedures 
were followed by restenosis. The clinical restenosis rate 
after the third angioplasty reported here was 43%. In a 
previous study from this institution (17,18), we found a 31% 
restenosis rate after the first and a 37% restenosis rate after 
the second angioplasty. Other reports document restenosis 
rates varying from 12 to 38% after the first procedure (1-13) 
and from 26 to 34% after the second. The 43% restenosis rate 
after the third angioplasty reported here is, therefore, higher 
than most reported restenosis rates after the first or second 
procedure. Our finding of a 53% restenosis rate after the 
Figure 2. Follow-up results in 74 patients undergoing a third, fourth 
or fifth coronary angioplasty for a second restenosis. RX = treat- 
ment; CABG = coronary artery bypass graft. The results are a 
composite of those after either a third, fourth or fifth procedure. 
fourth angioplasty is also consistent with an increased rate of 
restenosis with subsequent procedures. It appears that pa- 
tients with multiple restenoses in the past are more likely 
than patients without this history to have restenosis in the 
future. 
Factors associated with recurrent restenosis. Why some 
patients are more likely than others to exhibit restenosis is 
not known. Previous studies have determined clinical as well 
as anatomic factors associated with restenosis. Male gender, 
severity of angina before angioplasty (1,19), diabetes melli- 
tus, previous myocardial infarction (l), smoking (20), pre- 
procedural stenosis, residual stenosis, calcified stenosis 
(3,12), absence of intimal dissection (7,8), increased lesion 
length (21,22) and dilation of the left anterior descending 
artery (3,12) have all been associated with increased resten- 
osis rates (23,24). In the present study neither age, gender, 
impaired left ventricular contractility, serum cholesterol 
level, diabetes, continued smoking or percent diameter 
stenosis before the third angioplasty were associated with a 
subsequent third restenosis. One previous report (25) found 
that factors known to influence restenosis after the first 
angioplasty were not significant predictors of restenosis after 
the second procedure. In that same report, patients with an 
interval of <5 months between the first and the second 
procedure had an increased rate of restenosis. In the present 
study, although the mean time intervals from the first to the 
second and from the second to the third procedure were 
shorter in patients who subsequently developed a third 
restenosis, these differences were not significant. However, 
72% of patients for whom both time intervals were 53 
months had a third restenosis compared with only 38% of 
patients for whom either time interval was >3 months (p < 
0.05). Therefore, very short time intervals between previous 
restenoses are predictive of future restenoses. 
Our results also extend the data on increased restenosis 
rates previously reported for the left anterior descending 
artery to patients undergoing multiple repeat angioplasty 
procedures. Patients with recurrent restenosis of the left 
JACC Vol. 13, No. 2 I‘EIKSTEIN ET AL. 29.5 
February 1989:291-6 REPEAT ANGIOPI.ASl‘\ 
anterior descending artery constituted the majority (51%) of 
our study group and had the highest (57%) restenosis rate 
after the third angioplasty. 
Procedural and late deaths. There were two procedural 
deaths. One occurred in a 50 year old man who had previous 
coronary bypass surgery, prior anterior and inferior myocar- 
dial infarction and extremely poor left ventricular contrac- 
tility and was deemed inoperable by this institution’s cardio- 
vascular surgeons. With intraaortic balloon pump support, 
repeat restenoses in both the left circumflex artery and a vein 
graft to the left anterior descending artery were successfully 
redilated. He had ventricular fibrillation 4 days after the 
procedure. At emergency angiography the circumflex artery 
was occluded. The second procedural death occurred in a 71 
year old man who had successful dilation of repeat reste- 
noses in both the left circumflex and anterior descending 
arteries and a new lesion in the right coronary artery. He had 
ventricular fibrillation 1 day after the procedure. Emergency 
angiography demonstrated occlusion of the right coronary 
artery. 
There were also two late deaths. One occurred in a 59 
year old insulin-dependent diabetic man with diffuse occlu- 
sive coronary artery disease, previous anterior and inferior 
myocardial infarction, poor left ventricular contractility, and 
two prior bypass operations. He died after another myocar- 
dial infarction 5 months after a successful third angioplasty. 
The second late death occurred in a 71 year old woman with 
diffuse severe coronary artery disease, prior anterior myo- 
cardial infarction, poor left ventricular contractility and a 
history of nonsustained ventricular tachycardia. She had 
ventricular fibrillation and a cardiac arrest 2 months after her 
third procedure. 
Three of these four deuths occurred in patients who were 
not considered candidates for bypass surgery. They empha- 
size a small but important patient subgroup in our study. The 
choice between angioplasty and bypass surgery was not 
available to some patients. Repeat coronary angioplasty was 
the only remaining option and was often undertaken as a 
palliative procedure. 
Study limitations. A limitation of this study is the low rate 
(53%) of follow-up angiography. Nearly all symptomatic 
patients (97%) had a follow-up angiogram, but very few 
asymptomatic patients (9%) underwent a follow-up study. In 
previous reports (1,3,4,6,13), the rate of asymptomatic 
restenosis has varied from 4 to 19%. It is possible that some 
of our asymptomatic patients would demonstrate restenosis 
if they underwent repeat angiography. However, in each of 
these patients previous episodes of restenosis were associ- 
ated with return of angina1 symptoms. Therefore, we expect 
a very high correlation between symptoms and restenosis in 
this specific patient subgroup. 
A second limitation concerns the definition of restenosis. 
Using ~40% diameter narrowing as the definition of success 
and >50% diameter narrowing as the definition of restenosis, 
we could include patients with minimal (10 to 20%) changes 
in their lesions. However, the great majority of our patients 
had far more extensive changes. Of the 74 patients undergo- 
ing a third angioplasty, only 5% subsequently had a third 
restenosis that involved diameter narrowing of 50 to 60%; in 
most patients (88%) the restenosis involved >70% diameter 
narrowing. 
Clinical implications. Restenosis after a xcond angio- 
plasty procedure represents a difficult management decision 
for both the patient and physician. Restenosis rates were 
clearly increased after the third procedure. Still, a substan- 
tial number of patients became asymptomatic and required 
no further invasive procedures at long-term follow-up. Of 
those patients who did have a third restenosis, some had a 
fourth and one patient underwent a fifth angioplasty. Con- 
sidering all 74 patients undergoing a third angioplasty for a 
second restenosis, fully 64% were free ot@ngina after a third. 
fourth or fifth dilation. 
Therapeutic decisions must be tailored to the individual 
patient. The morbidity.and risk of coronary bypass surgery 
must be weighed against the risk, inconvenience and cost of 
multiple dilation procedures. Some patients are frustrated by 
the possibility of further restenosis and choose surgery. 
Others believe the risk of repeat restenosis is justitied if there 
is a possibility of avoiding surgery. The patient can be told 
that the risk of restenosis is increased with subsequent 
angioplasty procedures and approaches a 50% incidence 
when multiple procedures are required. Still. ‘t substantial 
number of patients are relieved of symptoms by the third OI 
fourth dilation. Armed with these data. the patient and 
physician can make a more informed decision. 
Conclusions. Restenosis rates after repeat coronary an- 
gioplasty procedures for recurrent restenosis are greater 
than those for initial procedures. The rate of restenosis was 
43% after the third angioplasty and 53% after the fourth. 
Despite higher restenosis rates, 64% of patients maintained 
long-term benefit after the third, fourth or fifth dilation. 
Restenosis rates were highest in patients with a shorter time 
interval between previous procedures and patients undergo- 
ing dilation of the left anterior descending artery. The 
decision to proceed with the third angioplasty for a second 
restenosis must be made on an individual basis influenced 
largely by relative risks and the patient’s willingness to 
undergo multiple angioplasty procedures. 
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